• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非线性混合效应模型中的设计:使用费多罗夫 - 韦恩算法进行优化以及二元协变量的Wald检验功效

Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.

作者信息

Retout Sylvie, Comets Emmanuelle, Samson Adeline, Mentré France

机构信息

Inserm, U738, Paris, France.

出版信息

Stat Med. 2007 Dec 10;26(28):5162-79. doi: 10.1002/sim.2910.

DOI:10.1002/sim.2910
PMID:17486667
Abstract

We extend the methodology for designs evaluation and optimization in nonlinear mixed effects models with an illustration of the decrease of human immunodeficiency virus viral load after antiretroviral treatment initiation described by a bi-exponential model. We first show the relevance of the predicted standard errors (SEs) given by the computation of the population Fisher information matrix using the R function PFIM, in comparison to those computed with the stochastic approximation expectation-maximization algorithm, implemented in the Monolix software. We then highlight the usefulness of the Fedorov-Wynn (FW) algorithm for designs optimization compared to the Simplex algorithm. From the predicted SE of PFIM, we compute the predicted power of the Wald test to detect a treatment effect as well as the number of subjects needed to achieve a given power. Using the FW algorithm, we investigate the influence of the design on the power and show that, for optimized designs with the same total number of samples, the power increases when the number of subjects increases and the number of samples per subject decreases. A simulation study is also performed with the nlme function of R to confirm this result and show the relevance of the predicted powers compared to those observed by simulation.

摘要

我们扩展了非线性混合效应模型中设计评估和优化的方法,并通过双指数模型描述的抗逆转录病毒治疗开始后人类免疫缺陷病毒病毒载量的下降进行了说明。我们首先展示了使用R函数PFIM计算总体费舍尔信息矩阵得到的预测标准误差(SEs)与在Monolix软件中实现的随机近似期望最大化算法计算的标准误差相比的相关性。然后,我们强调了与单纯形算法相比,费多罗夫 - 韦恩(FW)算法在设计优化方面的有用性。根据PFIM的预测SE,我们计算了检测治疗效果的Wald检验的预测功效以及达到给定功效所需的受试者数量。使用FW算法,我们研究了设计对功效的影响,并表明,对于具有相同样本总数的优化设计,当受试者数量增加且每个受试者的样本数量减少时,功效会增加。还使用R的nlme函数进行了模拟研究,以证实这一结果,并展示预测功效与模拟观察到的功效相比的相关性。

相似文献

1
Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.非线性混合效应模型中的设计:使用费多罗夫 - 韦恩算法进行优化以及二元协变量的Wald检验功效
Stat Med. 2007 Dec 10;26(28):5162-79. doi: 10.1002/sim.2910.
2
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.非线性混合效应多响应模型的费希尔信息矩阵:使用药代动力学/药效学模型评估一阶线性化的适用性
Stat Med. 2009 Jun 30;28(14):1940-56. doi: 10.1002/sim.3573.
3
The SAEM algorithm for group comparison tests in longitudinal data analysis based on non-linear mixed-effects model.基于非线性混合效应模型的纵向数据分析中用于组间比较检验的SAEM算法。
Stat Med. 2007 Nov 30;26(27):4860-75. doi: 10.1002/sim.2950.
4
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.多响应非线性混合效应模型中的设计评估与优化:PFIM 3.0。
Comput Methods Programs Biomed. 2010 Apr;98(1):55-65. doi: 10.1016/j.cmpb.2009.09.012. Epub 2009 Nov 4.
5
Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.交叉药代动力学研究中通过非线性混合效应模型进行的设计评价与优化。
Stat Med. 2012 May 20;31(11-12):1043-58. doi: 10.1002/sim.4390. Epub 2011 Oct 3.
6
Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.在药代动力学相互作用和生物等效性交叉试验中,基于非线性混合效应模型的试验模拟评估。
Stat Med. 2005 May 30;24(10):1509-24. doi: 10.1002/sim.2047.
7
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.非线性混合效应模型的费舍尔信息矩阵:依诺肝素群体药代动力学优化设计的评估与应用
Stat Med. 2002 Sep 30;21(18):2623-39. doi: 10.1002/sim.1041.
8
Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.基于模型的生物等效性交叉试验分析,采用随机逼近期望最大化算法。
Stat Med. 2011 Sep 20;30(21):2582-600. doi: 10.1002/sim.4286. Epub 2011 Jul 26.
9
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.PFIM 4.0,一个用于非线性混合效应模型设计评估和优化的扩展 R 程序。
Comput Methods Programs Biomed. 2018 Mar;156:217-229. doi: 10.1016/j.cmpb.2018.01.008. Epub 2018 Jan 11.
10
Impact of modelling intra-subject variability on tests based on non-linear mixed-effects models in cross-over pharmacokinetic trials with application to the interaction of tenofovir on atazanavir in HIV patients.在交叉药代动力学试验中,基于非线性混合效应模型的测试中模拟受试者内变异性的影响,并应用于替诺福韦对HIV患者阿扎那韦相互作用的研究。
Stat Med. 2007 Mar 15;26(6):1268-84. doi: 10.1002/sim.2622.

引用本文的文献

1
Using Fisher Information Matrix to predict uncertainty in covariate effects and power to detect their relevance in Non-Linear Mixed Effect Models in pharmacometrics.利用费希尔信息矩阵预测协变量效应的不确定性以及检测其在药物计量学非线性混合效应模型中的相关性的效能。
J Pharmacokinet Pharmacodyn. 2025 Jul 14;52(4):38. doi: 10.1007/s10928-025-09987-2.
2
Stochastic Version of EM Algorithm for Nonlinear Random Change-Point Models.非线性随机变点模型的期望最大化算法的随机版本
Proc Int Conf Stat Theory Appl ICSTA. 2021 Jul;2021. doi: 10.11159/icsta21.119.
3
PyMulSim: a method for computing node similarities between multilayer networks via graph isomorphism networks.
PyMulSim:一种通过图同构网络计算多层网络中节点相似度的方法。
BMC Bioinformatics. 2024 Jun 13;25(1):211. doi: 10.1186/s12859-024-05830-6.
4
Optimal Designs for Nonlinear Mixed-effects Models Using Competitive Swarm Optimizer with Mutated Agents.使用带变异个体的竞争型群体优化器的非线性混合效应模型的最优设计
Res Sq. 2023 Oct 5:rs.3.rs-3389537. doi: 10.21203/rs.3.rs-3389537/v1.
5
Metaheuristics for pharmacometrics.药物代谢动力学中的启发式算法。
CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1297-1309. doi: 10.1002/psp4.12714. Epub 2021 Oct 22.
6
Model-based approach to sampling optimization in studies of antibacterial drugs for infants and young children.基于模型的方法在婴儿和幼儿抗菌药物研究中的采样优化。
Clin Transl Sci. 2021 Jul;14(4):1543-1553. doi: 10.1111/cts.13018. Epub 2021 Apr 9.
7
Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.利拉鲁肽对7至11岁肥胖儿童人群的影响:一项评估安全性、耐受性、药代动力学和药效学的随机、双盲、安慰剂对照短期试验。
Pediatr Obes. 2019 May;14(5):e12495. doi: 10.1111/ijpo.12495. Epub 2019 Jan 17.
8
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.MPBPK-TMDD 模型用于单克隆抗体:替代模型、比较和可识别性问题。
J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):787-802. doi: 10.1007/s10928-018-9608-7. Epub 2018 Nov 10.
9
A minimal resting time of 25 min is needed before measuring stabilized blood pressure in subjects addressed for vascular investigations.在对接受血管检查的患者进行稳定血压测量之前,需要至少 25 分钟的休息时间。
Sci Rep. 2017 Oct 10;7(1):12893. doi: 10.1038/s41598-017-12775-9.
10
FPCA-based method to select optimal sampling schedules that capture between-subject variability in longitudinal studies.基于功能主成分分析的方法,用于选择在纵向研究中捕捉个体间变异性的最优抽样计划。
Biometrics. 2018 Mar;74(1):229-238. doi: 10.1111/biom.12714. Epub 2017 May 8.